首页|血细胞多参数指标联合检测在原发性免疫性血小板减少症病情评估中的应用价值

血细胞多参数指标联合检测在原发性免疫性血小板减少症病情评估中的应用价值

扫码查看
目的:分析血细胞多参数指标联合检测在原发性免疫性血小板减少症(ITP)病情评估中的应用价值。方法:选取2021年12月—2022年12月某院95例ITP患儿作为研究组,另选95例同期健康体检儿童作为对照组。比较2组受试者入组时血细胞参数指标[血小板平均体积(MPV)、血小板平均宽度(PDW)、血小板计数(PLT)、大血小板比例(P-LCR)],比较研究组不同预后ITP患儿入组时病情程度、治疗方案,以及治疗前后血细胞参数指标的差异,分析治疗后血细胞参数指标与疾病转归的相关性及预测ITP患儿疾病转归的价值。结果:入组时,研究组MPV、PDW、P-LCR[(11。45±1。75)fL、(17。15±2。38)%、(42。45±6。74)%]水平高于对照组[(9。49±1。55)几、(14。37±2。09)%、(23。10±4。57)%],PLT[(45。62±8。83)× 109/L]低于对照组[(228。97±48。20)× 109/L],差异均有统计学意义(P<0。05);治疗1、2个月后,研究组预后良好患儿MPV、PDW、P-LCR低于预后不良患儿,PLT高于预后不良患儿(P<0。05);治疗1、2个月后,MPV、PDW、P-LCR与疾病转归呈负相关(1 个月 r=-0。481、-0。550、-0。579;2 个月 r=-0。541、-0。583、-0。645,P 均<0。05),PLT 与疾病转归呈正相关(1 个月r=0。530;2个月r=0。582,P均<0。05);治疗1、2个月后,MPV、PLT、PDW、P-LCR联合预测患儿疾病转归的AUC分别为0。830、0。871,敏感度分别为77。78%、83。33%,特异度分别为88。31%、90。91%,均高于单一指标预测(P<0。05)。结论:联合检测MPV、PLT、PDW、P-LCR可辅助评估ITP病情,且在预测患儿疾病转归方面具有较高效能。
Application value of multi-parameter dynamic monitoring of blood cells in evaluation of primary immune thrombocytopenia
Objective:To analyze the application value of multi-parameter dynamic monitoring of blood cells in the evaluation of pri-mary immune thrombocytopenia(ITP).Methods:95 children with ITP who were hospitalized from December 2021 to December 2022 were selected as the observation group,and 95 healthy children with physical examination in the same period were selected as the con-trol group.Mean platelet volume(MPV),mean platelet width(PDW),platelet count(PLT),and proportion of large platelets(P-LCR)were compared between the two groups at the time of enrolment.Children with different prognosis of ITP(before and after treat-ment)were compared in terms of disease condition,therapy,and haematocrits parameters.Correlation between haematological parame-ter indices and disease regression was analyzed and the predictive value of disease regression for the children with ITP was assessed.Results:At the time of admission,MPV,PDW,and P-LCR were higher and PLT was lower in the observation group than in the control group(P<0.05).One month and two months after treatment,MPV,PDW and P-LCR of the children with good prognosis were lower than those with poor prognosis,and PLT was higher than those with poor prognosis(P<0.05).The result showed that MPV,PDW and P-LCR were negatively correlated with the disease outcome after 1 month and 2 months of treatment,while PLT was positively correlated with the disease outcome(P<0.05).One month and two months after the treatment,the ROC curve analysis showed that the area un-der the curve(AUC)of MPV,PLT,PDW and P-LCR in the joint prediction of the disease outcome of the children were 0.830 and 0.871,respectively,with sensitivity being 77.78%and 83.33%,and specificity being 88.31%and 90.91%,respectively.All of them were higher than that predicted by single index(P<0.05).Conclusion:Dynamic monitoring of MPV,PLT,PDW and P-LCR can assist in the assessment of ITP,and has high efficacy in predicting the disease outcome of children.

Primary immune thrombocytopeniaBlood cell multiple parametersDynamic monitoringDisease assessment

李丽君、乔志华、高毅

展开 >

河南省新乡市中心医院核医学科,453000

原发性免疫性血小板减少症 血细胞多参数 动态监测 病情评估

2024

淮海医药
蚌埠市医学科学情报站 《淮海医药》编辑部

淮海医药

影响因子:0.58
ISSN:1008-7044
年,卷(期):2024.42(1)
  • 20